Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive function after liver transplantation comparing tacrolimus formulations
DRKS00021108Phase 4Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Nov 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in Post-Transplant Immunosuppression (2 arms), sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Cognitive function. Started Nov 2020; status: completed.
02
Drugs
tacrolimus
03
Conditions
Post-Transplant Immunosuppression
Beyond the preview
Go deeper on DRKS00021108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00021108.